Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Laser acupoints: a Needle-Free hope for blocked tubes?

NCT ID NCT07351747

Disease control Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if laser acupoint therapy can help unblock fallopian tubes in women trying to get pregnant. 36 women aged 20-35 with blocked tubes will receive the treatment. The main goal is to see if the tubes open up, checked by X-ray before and 3 months after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 20-35 years - nulliparous. * Women diagnosed with fallopian tube obstruction. * Body mass index less than 30 kg/m2. * Consent to participate in the study. * General good health with no major co-existing medical conditions that could interfere with the treatment or outcomes. * No prior fertility treatments \[e.g., In vitro fertilization (IVF), intrauterine insemination (IUI)\] within the last 6 months. * Ability to attend all scheduled sessions and follow-up assessments. Exclusion Criteria: * Currently pregnant or breastfeeding. * History of pelvic surgery within the past year. * Presence of severe systemic diseases such as active cancer or severe cardiovascular diseases. * History of allergic reactions or adverse responses to acupuncture or laser therapies. * Currently undergoing hormonal therapy or use of hormonal contraceptives. * Current or recent history of genital tract infections, including sexually transmitted. infections, which could affect the reproductive system. * Presence of significant uterine anomalies diagnosed through imaging that could impact fertility. * Polycystic Ovary Syndrome (PCOS).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupoints are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fallopian tube disorder hydrosalpinx

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acupoints Fallopian tube obstruction LASER

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kafrelsheikh University (Faculty of Physical Therapy)

    RECRUITING

    Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.